Abstract
With this sub-project (described in the main proposal as Project 8), we intend to carry out essential tests that demonstrate that melanoma cells derived from patients respond to treatment with adenoviral vector bearing p14Arf and IFN-beta (interferon-beta). Here, we will explore the induction of cell death, the mechanism of cell death, the potential for activation of the immune system and…